Anisodamine (CAS 55869-99-3) Suppliers and Product Information

Anisodamine is a non-specific cholinergic antagonist and α1-adrenergic receptor inhibitor. It is structurally related to atropine and is considered less efficient and less toxic. Anisodamine has various therapeutic applications, including treatment of septic shock, circulatory disorders, organophosphorus poisoning, and radiation damage.

Anisodamine interferes with liposome structure, affects cell membrane, and may act as an antioxidant. It reduces cardiac conduction, prevents arrhythmia, and possesses potential anti-thrombotic functions. The compound is used in treating various disorders such as migraine, gastric ulcers, rheumatoid arthritis, and acute glomerular nephritis.

Frequently Asked Questions about Anisodamine

Q: What is the primary use of Anisodamine?

A: Anisodamine is primarily used as a non-specific cholinergic antagonist and α1-adrenergic receptor inhibitor. It has various therapeutic applications, including treatment of septic shock, circulatory disorders, and organophosphorus poisoning.

Q: How does Anisodamine compare to Atropine?

A: Anisodamine is structurally related to atropine but is considered less efficient and less toxic. Both compounds act as non-specific cholinergic antagonists.

Q: What are some potential side effects of Anisodamine?

A: While specific side effects are not mentioned in the provided information, as a cholinergic antagonist, potential side effects may include dry mouth, blurred vision, and constipation. However, it is considered less toxic than atropine.

Q: Is Anisodamine available for laboratory use?

A: Yes, anisodamine is available as a reagent for laboratory use only, as indicated by one of the suppliers (TargetMol Chemicals Inc.).